Sponsors

Early diagnosis of RA

The Binding SiteÆs new, highly specific and sensitive secondgeneration anti-CCP2 enzyme-linked immunosorbent assay (ELISA) kit is the latest addition to the companyÆs comprehensive range of autoimmune BINDAZYME assays.

The kit is intended as an aid in the early diagnosis of rheumatoid arthritis, measuring specific IgG autoantibodies against secondgeneration cyclic citrullinated peptides (CCP2) in human serum.

In common with all BINDAZYME assays, the new anti-CCP2 kit is automation friendly and easy to use. Its single-well ‘break apart’ format makes it cost effective and suitable for various levels of workload.

www.bindingsite.co.uk

Latest Issues

2nd Global Summit on Pathology

Rome, Italy
10-11 April, 2025

The 10 Year Plan - Clinical Innovations Expo

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025

Transforming Digital Pathology & AI: The Path Forward

Royal College Of Physicians Of Edinburgh
15 May, 2025

BSMT 40th Anniversary Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025